AlloVir
Why Robinhood?
You can watch AlloVir and buy or sell other stocks, ETFs, and their options commission-free!About ALVR
Kalaris Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for retinal diseases. It is focusing on developing TH103, a novel anti-VEGF agent targeted at treating neovascular and exudative retinal diseases.
ALVR Key Statistics
Stock Snapshot
The current AlloVir(ALVR) stock price is $9.81, with a market capitalization of 225.55M. The stock trades at a price-to-earnings (P/E) ratio of -2.22.
AlloVir(ALVR) stock opened on 2026-07-05 at —. The price climbed to — and dipped to —.
The AlloVir(ALVR)'s current trading volume is 0, compared to an average daily volume of 77.06K.
In the last year, AlloVir(ALVR) shares hit a 52-week high of $11.88 and a 52-week low of $2.14.
In the last year, AlloVir(ALVR) shares hit a 52-week high of $11.88 and a 52-week low of $2.14.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.